Trade Mark Journal No.2026/007 13 February 2026
WO0000001898836 (5)
Office of origin: United States of America
Date of International Registration:16 December 2025
Date of designation in the UK:
16 December 2025

International priority date claimed: 17 June 2025
(United States of America)
(99239065)
- Class 5
- Pharmaceutical preparations for use in the treatment of nicotine addiction and for the cessation of smoking or vaping; pharmaceutical preparations for use in reducing or eliminating nicotine cravings and withdrawal symptoms and for eliminating the urge to smoke or vape; pharmaceutical preparations for use as an aid to promote a reduction in smoking and vaping and for preventing a smoking or vaping relapse.
Achieve Life Sciences, Inc.
Representative: CHELSEAA ELIZABETH LARSEN Sheppard Mullin Richter & Hampton, LLP, 1540 El Camino Real, Suite 120, Menlo Park CA 94025, UNITED STATES OF AMERICA